Calliditas Therapeutics AB
F:LC8
Calliditas Therapeutics AB
F:LC8
Price:
17.83
EUR
0.34%
Market Closed
Market Cap:
€963.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Calliditas Therapeutics AB
F:LC8
|
SE |
|
P
|
PNM Resources Inc
F:98P
|
US |
|
China Gas Holdings Ltd
F:EBZ0
|
HK |
|
C
|
C P Pokphand Co Ltd
F:CPQA
|
HK |
|
Ceres Inc
OTC:CEEIF
|
JP |
|
I
|
Ironwood Pharmaceuticals Inc
F:I76
|
US |
|
Acast AB (publ)
F:0PN
|
SE |
|
W
|
Wijaya Karya (Persero) Tbk PT
XMUN:5AA
|
ID |
|
Net Digital AG
F:VRL
|
DE |
|
B
|
Banco Santander-Chile
SWB:BSA
|
CL |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LC8's stock price target?
Not Available
LC8 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Calliditas Therapeutics AB?
Projected CAGR
57%
57%
The compound annual growth rate for Revenue over the next 3 years is 57%.
